Meta Health Limited (SGX:5DX)
Singapore flag Singapore · Delayed Price · Currency is SGD
0.0030
0.00 (0.00%)
At close: Aug 14, 2026

Meta Health Statistics

Total Valuation

Meta Health has a market cap or net worth of SGD 3.96 million. The enterprise value is 6.00 million.

Market Cap3.96M
Enterprise Value 6.00M

Important Dates

The next estimated earnings date is Monday, November 9, 2026.

Earnings Date Nov 9, 2026
Ex-Dividend Date n/a

Share Statistics

Meta Health has 1.32 billion shares outstanding. The number of shares has increased by 36.17% in one year.

Current Share Class 1.32B
Shares Outstanding 1.32B
Shares Change (YoY) +36.17%
Shares Change (QoQ) -22.75%
Owned by Insiders (%) 19.28%
Owned by Institutions (%) 22.81%
Float 1.02B

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 2.67
PB Ratio -2.06
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 4.05
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.41

Current Ratio 0.41
Quick Ratio 0.40
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF -34.17
Interest Coverage -4.86

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -33.32%
Return on Invested Capital (ROIC) -81.29%
Return on Capital Employed (ROCE) 49.49%
Weighted Average Cost of Capital (WACC) 7.02%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover 0.86
Inventory Turnover n/a

Taxes

Income Tax -5,147
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -50.00% in the last 52 weeks. The beta is 0.59, so Meta Health's price volatility has been lower than the market average.

Beta (5Y) 0.59
52-Week Price Change -50.00%
50-Day Moving Average 0.00
200-Day Moving Average 0.00
Relative Strength Index (RSI) 38.13
Average Volume (20 Days) 885,030

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Meta Health had revenue of SGD 1.48 million and -1.12 million in losses. Loss per share was -0.00.

Revenue1.48M
Gross Profit 1.37M
Operating Income -921,495
Pretax Income -1.11M
Net Income -1.12M
EBITDA -918,640
EBIT -921,495
Loss Per Share -0.00
Full Income Statement

Balance Sheet

The company has 247,000 in cash and 2.40 million in debt, with a net cash position of -2.15 million or -0.00 per share.

Cash & Cash Equivalents 247,000
Total Debt 2.40M
Net Cash -2.15M
Net Cash Per Share -0.00
Equity (Book Value) -1.92M
Book Value Per Share -0.00
Working Capital -2.16M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -65,764 and capital expenditures -4,451, giving a free cash flow of -70,215.

Operating Cash Flow -65,764
Capital Expenditures -4,451
Depreciation & Amortization 2,855
Net Borrowing 624,292
Free Cash Flow -70,215
FCF Per Share -0.00
Full Cash Flow Statement

Margins

Gross margin is 92.61%, with operating and profit margins of -62.22% and -75.52%.

Gross Margin 92.61%
Operating Margin -62.22%
Pretax Margin -75.01%
Profit Margin -75.52%
EBITDA Margin -62.03%
EBIT Margin -62.22%
FCF Margin n/a

Dividends & Yields

Meta Health does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -36.17%
Shareholder Yield -36.17%
Earnings Yield -28.24%
FCF Yield -1.77%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 4